JP2007510935A - 多次元電気泳動装置 - Google Patents
多次元電気泳動装置 Download PDFInfo
- Publication number
- JP2007510935A JP2007510935A JP2006540004A JP2006540004A JP2007510935A JP 2007510935 A JP2007510935 A JP 2007510935A JP 2006540004 A JP2006540004 A JP 2006540004A JP 2006540004 A JP2006540004 A JP 2006540004A JP 2007510935 A JP2007510935 A JP 2007510935A
- Authority
- JP
- Japan
- Prior art keywords
- analyte
- separation
- concentrators
- concentrator
- interest
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001844 multi-dimensional electrophoresis Methods 0.000 title description 2
- 239000012491 analyte Substances 0.000 claims abstract description 636
- 238000000926 separation method Methods 0.000 claims abstract description 499
- 238000001962 electrophoresis Methods 0.000 claims abstract description 130
- 239000000126 substance Substances 0.000 claims abstract description 37
- 210000005239 tubule Anatomy 0.000 claims description 212
- 238000000034 method Methods 0.000 claims description 174
- 239000003446 ligand Substances 0.000 claims description 156
- 239000012488 sample solution Substances 0.000 claims description 127
- 239000011159 matrix material Substances 0.000 claims description 77
- 239000000243 solution Substances 0.000 claims description 60
- 102000004169 proteins and genes Human genes 0.000 claims description 57
- 108090000623 proteins and genes Proteins 0.000 claims description 57
- 239000000872 buffer Substances 0.000 claims description 54
- 239000000523 sample Substances 0.000 claims description 50
- 239000011324 bead Substances 0.000 claims description 49
- 239000007853 buffer solution Substances 0.000 claims description 49
- 201000010099 disease Diseases 0.000 claims description 44
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 44
- 239000012530 fluid Substances 0.000 claims description 44
- 239000000090 biomarker Substances 0.000 claims description 41
- 230000003750 conditioning effect Effects 0.000 claims description 29
- 238000004458 analytical method Methods 0.000 claims description 26
- 229920000642 polymer Polymers 0.000 claims description 25
- 238000006243 chemical reaction Methods 0.000 claims description 24
- 230000035945 sensitivity Effects 0.000 claims description 24
- 239000012149 elution buffer Substances 0.000 claims description 19
- 238000004853 microextraction Methods 0.000 claims description 15
- 238000005842 biochemical reaction Methods 0.000 claims description 13
- 239000012634 fragment Substances 0.000 claims description 12
- 210000004027 cell Anatomy 0.000 claims description 11
- 230000005684 electric field Effects 0.000 claims description 11
- 238000001155 isoelectric focusing Methods 0.000 claims description 11
- 239000012468 concentrated sample Substances 0.000 claims description 10
- 230000001965 increasing effect Effects 0.000 claims description 10
- 230000005291 magnetic effect Effects 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 230000003834 intracellular effect Effects 0.000 claims description 9
- 230000000717 retained effect Effects 0.000 claims description 8
- 230000036267 drug metabolism Effects 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 235000000346 sugar Nutrition 0.000 claims description 5
- 230000003100 immobilizing effect Effects 0.000 claims description 4
- 230000004044 response Effects 0.000 claims description 4
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 3
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 238000002955 isolation Methods 0.000 claims description 3
- 230000004807 localization Effects 0.000 claims 3
- 102000005744 Glycoside Hydrolases Human genes 0.000 claims 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 claims 1
- 102000057297 Pepsin A Human genes 0.000 claims 1
- 108090000284 Pepsin A Proteins 0.000 claims 1
- 210000003850 cellular structure Anatomy 0.000 claims 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 claims 1
- 229960003151 mercaptamine Drugs 0.000 claims 1
- 229940111202 pepsin Drugs 0.000 claims 1
- 238000010168 coupling process Methods 0.000 abstract description 5
- 230000008878 coupling Effects 0.000 abstract description 4
- 238000005859 coupling reaction Methods 0.000 abstract description 4
- 230000032258 transport Effects 0.000 description 179
- 238000005251 capillar electrophoresis Methods 0.000 description 48
- 238000001514 detection method Methods 0.000 description 36
- 238000004587 chromatography analysis Methods 0.000 description 31
- 238000004094 preconcentration Methods 0.000 description 26
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 19
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 19
- 108090000765 processed proteins & peptides Proteins 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 17
- 101100441413 Caenorhabditis elegans cup-15 gene Proteins 0.000 description 15
- 238000010828 elution Methods 0.000 description 12
- 238000004949 mass spectrometry Methods 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- 238000005515 capillary zone electrophoresis Methods 0.000 description 9
- 239000012141 concentrate Substances 0.000 description 9
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- 239000002699 waste material Substances 0.000 description 9
- 238000003795 desorption Methods 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 108090001090 Lectins Proteins 0.000 description 7
- 102000004856 Lectins Human genes 0.000 description 7
- 239000000427 antigen Substances 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 238000002045 capillary electrochromatography Methods 0.000 description 7
- 239000002523 lectin Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- 230000002411 adverse Effects 0.000 description 6
- 239000012916 chromogenic reagent Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 238000001386 capillary affinity electrophoresis Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 238000002470 solid-phase micro-extraction Methods 0.000 description 5
- 238000009007 Diagnostic Kit Methods 0.000 description 4
- 102000003886 Glycoproteins Human genes 0.000 description 4
- 108090000288 Glycoproteins Proteins 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000013060 biological fluid Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000005370 electroosmosis Methods 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000004811 liquid chromatography Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 108091092878 Microsatellite Proteins 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000001042 affinity chromatography Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 229920001222 biopolymer Polymers 0.000 description 3
- 238000000738 capillary electrophoresis-mass spectrometry Methods 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000001143 conditioned effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 238000012510 peptide mapping method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 125000005372 silanol group Chemical group 0.000 description 3
- 238000003980 solgel method Methods 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108091023037 Aptamer Proteins 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- 102000002265 Human Growth Hormone Human genes 0.000 description 2
- 108010000521 Human Growth Hormone Proteins 0.000 description 2
- 239000000854 Human Growth Hormone Substances 0.000 description 2
- 108010093096 Immobilized Enzymes Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 101710120037 Toxin CcdB Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000002983 circular dichroism Methods 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000009795 derivation Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical group [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000011209 electrochromatography Methods 0.000 description 2
- 238000000132 electrospray ionisation Methods 0.000 description 2
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- -1 human growth hormone Chemical compound 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 238000001499 laser induced fluorescence spectroscopy Methods 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 239000000813 peptide hormone Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 239000004328 sodium tetraborate Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000004885 tandem mass spectrometry Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000004454 trace mineral analysis Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- OCFIRCHPJWLACG-VKHMYHEASA-N (2r)-2-azaniumyl-3-(methylcarbamoylsulfanyl)propanoate Chemical compound CNC(=O)SC[C@H](N)C(O)=O OCFIRCHPJWLACG-VKHMYHEASA-N 0.000 description 1
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 0 CC(C*(C(CC1C)=O)C1=O)[U]C(CC1)CCC1[U](*)=O Chemical compound CC(C*(C(CC1C)=O)C1=O)[U]C(CC1)CCC1[U](*)=O 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000786137 Halogeton glomeratus Species 0.000 description 1
- 101000987586 Homo sapiens Eosinophil peroxidase Proteins 0.000 description 1
- 101000920686 Homo sapiens Erythropoietin Proteins 0.000 description 1
- 241000699696 Meriones Species 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108010089430 Phosphoproteins Proteins 0.000 description 1
- 102000007982 Phosphoproteins Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 241001435194 Rhincodon typus Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical class OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 238000011953 bioanalysis Methods 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004130 chiral capillary electrophoresis Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000001425 electrospray ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 238000010201 enrichment analysis Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 108060003552 hemocyanin Proteins 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000001597 immobilized metal affinity chromatography Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 210000005061 intracellular organelle Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 238000012775 microarray technology Methods 0.000 description 1
- 238000004226 microchip electrophoresis Methods 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000005232 molecular self-assembly Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003053 polystyrene-divinylbenzene Polymers 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000010206 sensitivity analysis Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44756—Apparatus specially adapted therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44708—Cooling
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44743—Introducing samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
- G01N33/561—Immunoelectrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/405—Concentrating samples by adsorption or absorption
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51818603P | 2003-11-07 | 2003-11-07 | |
| PCT/US2004/038401 WO2005047882A2 (en) | 2003-11-07 | 2004-11-03 | Multi-dimensional electrophoresis apparatus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007510935A true JP2007510935A (ja) | 2007-04-26 |
| JP2007510935A5 JP2007510935A5 (https=) | 2007-12-20 |
Family
ID=34590232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006540004A Pending JP2007510935A (ja) | 2003-11-07 | 2004-11-03 | 多次元電気泳動装置 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US8182746B2 (https=) |
| EP (1) | EP1706735B1 (https=) |
| JP (1) | JP2007510935A (https=) |
| CA (1) | CA2563310A1 (https=) |
| WO (1) | WO2005047882A2 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6406604B1 (en) * | 1999-11-08 | 2002-06-18 | Norberto A. Guzman | Multi-dimensional electrophoresis apparatus |
| US8007725B2 (en) | 2003-11-07 | 2011-08-30 | Princeton Biochemicals, Inc. | Electrophoresis apparatus having valve system |
| CA2563310A1 (en) | 2003-11-07 | 2005-05-26 | Princeton Biochemicals, Inc. | Multi-dimensional electrophoresis apparatus |
| US20110071051A1 (en) * | 2008-05-27 | 2011-03-24 | Koninklijke Philips Electronics N.V. | Biochip for frationating and detecting analytes |
| US8361294B2 (en) | 2009-06-26 | 2013-01-29 | Yi Wang | Monolithic electrophoresis gel system |
| US8361293B2 (en) | 2009-06-26 | 2013-01-29 | Yi Wang | Monolithic electrophoresis gel system |
| US8449745B2 (en) | 2009-06-26 | 2013-05-28 | Yi Wang | Monolithic electrophoresis flat gel system |
| US8277659B2 (en) * | 2010-09-23 | 2012-10-02 | Battelle Memorial Institute | Microchip capillary electrophoresis absent electrokinetic injection |
| US9502225B2 (en) | 2012-06-20 | 2016-11-22 | The University Of North Carolina At Chapel Hill | Integrated sample processing for electrospray ionization devices |
| CN104297469B (zh) * | 2013-07-15 | 2017-02-08 | 艾博生物医药(杭州)有限公司 | 一种免疫读取设备以及该设备的校准方法 |
| WO2015179098A1 (en) | 2014-05-21 | 2015-11-26 | Integenx Inc. | Fluidic cartridge with valve mechanism |
| WO2016048687A1 (en) * | 2014-09-24 | 2016-03-31 | Battelle Memorial Institute | System and method of preconcentrating analytes in a microfluidic device |
| US10690627B2 (en) | 2014-10-22 | 2020-06-23 | IntegenX, Inc. | Systems and methods for sample preparation, processing and analysis |
| USD923817S1 (en) * | 2016-03-30 | 2021-06-29 | Princeton Biochemicals, Inc | Analyte concentrator-microreactor device |
| EP3510391B1 (en) * | 2016-09-09 | 2025-03-05 | Life Technologies Corporation | Capillary electrophoresis cathode systems and methods |
| BR112019006835A2 (pt) * | 2016-10-07 | 2019-06-25 | Boehringer Ingelheim Vetmedica Gmbh | sistema de análise e método para testagem de uma amostra |
| CN106589053B (zh) * | 2016-12-09 | 2020-01-14 | 华中师范大学 | 一种多维串联凝胶电泳系统、电泳方法及试剂盒 |
| EP3376212B1 (en) * | 2017-03-17 | 2020-01-29 | Ricoh Company Ltd. | Chemiluminescence analyzer, blood purification apparatus, and blood purification system |
| US11198118B2 (en) * | 2017-03-29 | 2021-12-14 | Princeton Biochemicals, Inc. | Integrated modular unit containing one or more analyte concentrator-microreactor devices to be coupled to a cartridge-cassette and methods of operation |
| US11446663B2 (en) | 2018-01-26 | 2022-09-20 | Aincobio Llc | Method and apparatus for isolating and detecting biological and other particles |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| CN110917877B (zh) * | 2019-12-17 | 2023-10-24 | 吉林大学 | 正交谐振电泳装置 |
| US11287396B2 (en) * | 2020-06-05 | 2022-03-29 | Princeton Biochemicals, Inc. | Method and system for simultaneous determination of multiple measurable biomarkers during the development of a communicable disease |
| US20250177972A1 (en) * | 2023-12-05 | 2025-06-05 | Hugh Califf | Integrated analysis system for the rapid measuring and recording of data from a host |
| CN121410077B (zh) * | 2025-12-30 | 2026-04-07 | 四川省科源工程技术测试中心有限责任公司 | 基于电化学控制变量分析法的土壤成分测定装置 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000314719A (ja) * | 1999-04-30 | 2000-11-14 | Shimadzu Corp | 電気泳動チップ |
| WO2001035089A1 (en) * | 1999-11-08 | 2001-05-17 | Guzman Norberto A | Multi-dimensional electrophoresis apparatus |
Family Cites Families (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816123A (en) | 1986-04-16 | 1989-03-28 | The Perkin-Elmer Corporation | Method of fabricating capillary electrophoresis separation channels |
| US5202010A (en) | 1987-11-25 | 1993-04-13 | Princeton Biochemicals, Inc. | Automated capillary electrophoresis apparatus |
| US5045172A (en) | 1987-11-25 | 1991-09-03 | Princeton Biochemicals, Inc. | Capillary electrophoresis apparatus |
| DE68927019T2 (de) | 1988-04-29 | 1997-01-23 | Beckman Instruments Inc | Kassette mit einem kapillaren Detektor für Elektroforese |
| US6001230A (en) | 1988-04-29 | 1999-12-14 | Beckman Coulter, Inc. | Automated capillary electrophoresis apparatus |
| EP0356160A3 (en) | 1988-08-24 | 1991-09-11 | The Board Of Trustees Of The Leland Stanford Junior University | Capillary device |
| US5770029A (en) | 1996-07-30 | 1998-06-23 | Soane Biosciences | Integrated electrophoretic microdevices |
| US5246577A (en) | 1990-05-29 | 1993-09-21 | Millipore Corporation | Apparatus for effecting capillary electrophoresis |
| US5340452A (en) | 1991-02-01 | 1994-08-23 | Beckman Instruments, Inc. | On-column preconcentration of samples in capillary electrophoresis |
| US5516409A (en) | 1991-02-28 | 1996-05-14 | Hitachi, Ltd. | DNA detector and DNA detection method |
| US5453382A (en) | 1991-08-05 | 1995-09-26 | Indiana University Foundation | Electrochromatographic preconcentration method |
| US5413686A (en) | 1992-07-17 | 1995-05-09 | Beckman Instruments, Inc. | Multi-channel automated capillary electrophoresis analyzer |
| US5958202A (en) | 1992-09-14 | 1999-09-28 | Perseptive Biosystems, Inc. | Capillary electrophoresis enzyme immunoassay |
| US5348633A (en) | 1993-01-22 | 1994-09-20 | Northeastern University | Method for quantitating trace amounts of an analyte in a sample by affinity capillary electrophoresis |
| US5324401A (en) | 1993-02-05 | 1994-06-28 | Iowa State University Research Foundation, Inc. | Multiplexed fluorescence detector system for capillary electrophoresis |
| US5730850A (en) | 1993-04-23 | 1998-03-24 | Hitachi, Ltd. | Capillary array electrophoresis system |
| US6020208A (en) | 1994-05-27 | 2000-02-01 | Baylor College Of Medicine | Systems for surface-enhanced affinity capture for desorption and detection of analytes |
| US5439578A (en) | 1993-06-03 | 1995-08-08 | The Governors Of The University Of Alberta | Multiple capillary biochemical analyzer |
| WO1995010344A1 (en) | 1993-10-14 | 1995-04-20 | Sarasep, Inc. | Beaded capillaries for capillary electrophoresis and chromatographic separations |
| US5503805A (en) * | 1993-11-02 | 1996-04-02 | Affymax Technologies N.V. | Apparatus and method for parallel coupling reactions |
| US5423966A (en) * | 1994-01-25 | 1995-06-13 | Perkin-Elmer Corporation | On line ion contaminant removal apparatus and method for capillary electrophoresis |
| DE69422604T2 (de) | 1994-03-08 | 2000-06-08 | Zeptosens Ag, Witterwil | Vorrichtung und Verfahren, die Bioaffinitätsassay und elektrophoretische Auftrennung kombinieren |
| US5637458A (en) | 1994-07-20 | 1997-06-10 | Sios, Inc. | Apparatus and method for the detection and assay of organic molecules |
| US6001229A (en) | 1994-08-01 | 1999-12-14 | Lockheed Martin Energy Systems, Inc. | Apparatus and method for performing microfluidic manipulations for chemical analysis |
| AU1837495A (en) * | 1994-10-13 | 1996-05-06 | Horus Therapeutics, Inc. | Computer assisted methods for diagnosing diseases |
| US5571410A (en) | 1994-10-19 | 1996-11-05 | Hewlett Packard Company | Fully integrated miniaturized planar liquid sample handling and analysis device |
| US5585069A (en) * | 1994-11-10 | 1996-12-17 | David Sarnoff Research Center, Inc. | Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis |
| US5560811A (en) | 1995-03-21 | 1996-10-01 | Seurat Analytical Systems Incorporated | Capillary electrophoresis apparatus and method |
| US5800692A (en) | 1995-04-17 | 1998-09-01 | Mayo Foundation For Medical Education And Research | Preseparation processor for use in capillary electrophoresis |
| US5582705A (en) | 1995-05-19 | 1996-12-10 | Iowa State University Research Foundation, Inc. | Multiplexed capillary electrophoresis system |
| US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| JP3515646B2 (ja) | 1995-09-18 | 2004-04-05 | 大塚電子株式会社 | マルチキャピラリ電気泳動装置 |
| US5661028A (en) | 1995-09-29 | 1997-08-26 | Lockheed Martin Energy Systems, Inc. | Large scale DNA microsequencing device |
| US5942443A (en) | 1996-06-28 | 1999-08-24 | Caliper Technologies Corporation | High throughput screening assay systems in microscale fluidic devices |
| US6074827A (en) * | 1996-07-30 | 2000-06-13 | Aclara Biosciences, Inc. | Microfluidic method for nucleic acid purification and processing |
| GB9624927D0 (en) * | 1996-11-29 | 1997-01-15 | Oxford Glycosciences Uk Ltd | Gels and their use |
| US6060208A (en) * | 1996-12-16 | 2000-05-09 | Creo Products Inc. | Method for matching optical density in color proofing |
| DK1179585T3 (da) * | 1997-12-24 | 2008-11-10 | Cepheid | Indretning og fremgangsmåde til lysis |
| FR2774472B1 (fr) | 1998-01-30 | 2000-04-21 | Centre Nat Rech Scient | Perfectionnements aux systemes d'electrophorese multicapillaire |
| US6054047A (en) | 1998-03-27 | 2000-04-25 | Synsorb Biotech, Inc. | Apparatus for screening compound libraries |
| CA2240325A1 (en) | 1998-03-27 | 1998-11-14 | Synsorb Biotech, Inc. | Methods for screening compound libraries |
| US6224728B1 (en) | 1998-04-07 | 2001-05-01 | Sandia Corporation | Valve for fluid control |
| US6534262B1 (en) | 1998-05-14 | 2003-03-18 | Whitehead Institute For Biomedical Research | Solid phase technique for selectively isolating nucleic acids |
| US6013165A (en) | 1998-05-22 | 2000-01-11 | Lynx Therapeutics, Inc. | Electrophoresis apparatus and method |
| US6375901B1 (en) | 1998-06-29 | 2002-04-23 | Agilent Technologies, Inc. | Chemico-mechanical microvalve and devices comprising the same |
| US6387234B1 (en) | 1998-08-31 | 2002-05-14 | Iowa State University Research Foundation, Inc. | Integrated multiplexed capillary electrophoresis system |
| US6948843B2 (en) * | 1998-10-28 | 2005-09-27 | Covaris, Inc. | Method and apparatus for acoustically controlling liquid solutions in microfluidic devices |
| US20020006359A1 (en) | 1998-11-25 | 2002-01-17 | Affymetrix, Inc. | Microplate sample and reagent loading system |
| US6270644B1 (en) | 1999-01-27 | 2001-08-07 | Affymetrix, Inc. | Capillary array electrophoresis scanner |
| EP1048951A1 (en) | 1999-04-26 | 2000-11-02 | ScreenTec B.V. | Mass spectrometry-based technologies for continuous flow biossays using known ligands |
| EP1048950A1 (en) | 1999-04-26 | 2000-11-02 | ScreenTec B.V. | Identification of ligands for orphan receptors using on-line coupling of mass spectrometry to continuous-flow separation techniques |
| US6623945B1 (en) | 1999-09-16 | 2003-09-23 | Motorola, Inc. | System and method for microwave cell lysing of small samples |
| JP3896739B2 (ja) | 1999-10-29 | 2007-03-22 | 株式会社日立製作所 | キャピラリー電気泳動装置 |
| US7329388B2 (en) | 1999-11-08 | 2008-02-12 | Princeton Biochemicals, Inc. | Electrophoresis apparatus having staggered passage configuration |
| US6408884B1 (en) | 1999-12-15 | 2002-06-25 | University Of Washington | Magnetically actuated fluid handling devices for microfluidic applications |
| JP2001255301A (ja) | 2000-03-08 | 2001-09-21 | Shimadzu Corp | 電気泳動装置 |
| WO2001070381A2 (en) * | 2000-03-21 | 2001-09-27 | Covaris, Inc. | Method and apparatus for acoustically controlling liquid solutions in microfluidic devices |
| US6562214B1 (en) | 2000-06-30 | 2003-05-13 | Beckman Coulter, Inc. | Laminated capillary array assembly |
| US6544396B1 (en) | 2000-07-20 | 2003-04-08 | Symyx Technologies, Inc. | Multiplexed capillary electrophoresis system |
| CA2314398A1 (en) | 2000-08-10 | 2002-02-10 | Edward Shipwash | Microarrays and microsystems for amino acid analysis and protein sequencing |
| US6777826B2 (en) * | 2000-09-13 | 2004-08-17 | Mazda Motor Corporation | Anti-theft system for vehicle |
| US6783649B2 (en) | 2000-12-01 | 2004-08-31 | Cetek Corporation | High throughput capillary electrophoresis system |
| JP2004515786A (ja) | 2000-12-14 | 2004-05-27 | ポール・ストルーバント | 特異的ファージ捕捉プロテオミクス |
| EP1354193B1 (en) | 2001-01-26 | 2007-06-06 | Biocal Technology, Inc. | Optical detection in a multi-channel bio-separation system |
| WO2002064253A2 (en) | 2001-02-09 | 2002-08-22 | Microchem Solutions | Method and apparatus for sample injection in microfabricated devices |
| US6596140B2 (en) | 2001-05-01 | 2003-07-22 | Applera Corporation | Multi-channel capillary electrophoresis device and method |
| ATE458199T1 (de) * | 2001-05-04 | 2010-03-15 | Biosite Inc | Diagnostische marker der akuten koronaren syndrome und ihre verwendungen |
| FR2825649B1 (fr) | 2001-06-08 | 2003-10-17 | Francois Paul Geli | Support pour analyse comparatives d'echantillons sur micro-colonnes de fractionnement avec gradients de longueur, phases stationnaires alternees, et elutions digitalisees |
| CA2456078A1 (en) * | 2001-08-03 | 2003-02-13 | Cetek Corporation | Microscale affinity purification system |
| WO2003027028A1 (en) | 2001-09-28 | 2003-04-03 | Applera Corporation | Multi-capillary array electrophoresis device |
| DE60237531D1 (de) | 2001-10-11 | 2010-10-14 | Aviva Biosciences Corp | Verfahren zum trennen von seltenen zellen von fluidproben |
| US7577476B2 (en) * | 2001-10-26 | 2009-08-18 | Athena Feminine Technologies, Inc | System and method for transducing, sensing, or affecting vaginal or body conditions, and/or stimulating perineal musculature and nerves using 2-way wireless communications |
| WO2003038424A1 (en) | 2001-11-02 | 2003-05-08 | Imperial College Innovations Limited | Capillary electrophoresis microchip, system and method |
| JP3979830B2 (ja) | 2001-12-04 | 2007-09-19 | 株式会社日立ハイテクノロジーズ | マルチキャピラリー電気泳動装置 |
| JP2003186989A (ja) * | 2001-12-13 | 2003-07-04 | Nikon Corp | ネットワーク往診方法 |
| WO2003059935A2 (en) | 2001-12-21 | 2003-07-24 | Immunex Corporation | Methods for purifying protein |
| ES2346424T3 (es) | 2002-04-12 | 2010-10-15 | Colorado School Of Mines | Procedimiento de deteccion de bajas concentraciones de una bacteria diana que utiliza fagos para infectar celulas bacterianas diana. |
| JP4038386B2 (ja) | 2002-04-26 | 2008-01-23 | 株式会社日立ハイテクノロジーズ | キャピラリアレイ及び電気泳動装置 |
| US8007725B2 (en) | 2003-11-07 | 2011-08-30 | Princeton Biochemicals, Inc. | Electrophoresis apparatus having valve system |
| CA2563310A1 (en) | 2003-11-07 | 2005-05-26 | Princeton Biochemicals, Inc. | Multi-dimensional electrophoresis apparatus |
| US7736890B2 (en) | 2003-12-31 | 2010-06-15 | President And Fellows Of Harvard College | Assay device and method |
-
2004
- 2004-11-03 CA CA002563310A patent/CA2563310A1/en not_active Abandoned
- 2004-11-03 EP EP04811197.5A patent/EP1706735B1/en not_active Expired - Lifetime
- 2004-11-03 JP JP2006540004A patent/JP2007510935A/ja active Pending
- 2004-11-03 WO PCT/US2004/038401 patent/WO2005047882A2/en not_active Ceased
-
2007
- 2007-10-31 US US11/981,479 patent/US8182746B2/en not_active Expired - Fee Related
-
2015
- 2015-09-28 US US14/868,328 patent/US10408789B2/en not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000314719A (ja) * | 1999-04-30 | 2000-11-14 | Shimadzu Corp | 電気泳動チップ |
| WO2001035089A1 (en) * | 1999-11-08 | 2001-05-17 | Guzman Norberto A | Multi-dimensional electrophoresis apparatus |
| JP2003514226A (ja) * | 1999-11-08 | 2003-04-15 | グズマン・ノーバート・エー | 多次元電気泳動装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005047882A2 (en) | 2005-05-26 |
| WO2005047882A3 (en) | 2005-10-20 |
| US20160123925A1 (en) | 2016-05-05 |
| CA2563310A1 (en) | 2005-05-26 |
| EP1706735B1 (en) | 2017-01-04 |
| US10408789B2 (en) | 2019-09-10 |
| US8182746B2 (en) | 2012-05-22 |
| US20080223722A1 (en) | 2008-09-18 |
| EP1706735A2 (en) | 2006-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11262330B2 (en) | Disease detection system and method | |
| US10408789B2 (en) | Disease detection system and method | |
| US7329388B2 (en) | Electrophoresis apparatus having staggered passage configuration | |
| US6406604B1 (en) | Multi-dimensional electrophoresis apparatus | |
| US9482602B2 (en) | Integrated modular unit including an analyte concentrator-microreactor device connected to a cartridge-cassette | |
| US8865075B2 (en) | Multi-task immunoaffinity device secured to a peripheral box and integrated to a capillary electrophoresis apparatus | |
| JP2005502864A (ja) | 被分析物を分離する方法および装置 | |
| AU2002360282A1 (en) | Microflludic system for proteome analysis | |
| JP2000515978A (ja) | 統合マイクロフルイディック素子 | |
| US11198118B2 (en) | Integrated modular unit containing one or more analyte concentrator-microreactor devices to be coupled to a cartridge-cassette and methods of operation | |
| Peng et al. | Recent innovations in protein separation on microchips by electrophoretic methods | |
| JP2004537719A (ja) | 微小規模アフィニティー精製システム | |
| US20160341694A1 (en) | Method and apparatus to concentrate and detect an analyte in a sample | |
| Changa et al. | Advanced capillary and microchip electrophoretic techniques for proteomics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071102 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071102 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100526 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100608 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100902 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100909 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100930 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20101007 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20101105 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20101112 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110215 |